UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $48,000 | -35.1% | 16,000 | 0.0% | 0.01% | -38.9% |
Q2 2021 | $74,000 | -52.3% | 16,000 | -38.2% | 0.02% | -60.9% |
Q1 2021 | $155,000 | +14.0% | 25,888 | 0.0% | 0.05% | -9.8% |
Q4 2020 | $136,000 | +88.9% | 25,888 | +24.7% | 0.05% | +75.9% |
Q3 2020 | $72,000 | – | 20,766 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |